HealthcareServices

Immune Response Testing Market Forecast: What to Expect by 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Immune Response Testing Market From 2025 To 2034?

The immune response testing market size has demonstrated rapid expansion in recent years. It is projected to expand from $14.77 billion in 2024 to $16.36 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.7%. This historical growth can be attributed to several factors, including an intensified focus on monitoring vaccine efficacy, the expanding application of immunotherapy in treating cancer, increased understanding of immune system health, the establishment of more global disease surveillance programs, rising investments in biopharmaceutical research and development, and a greater need for transplant compatibility assessments.

The immune response testing market size is anticipated to experience rapid expansion over the next few years, projected to grow to $24.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. This growth in the forecast period can be attributed to factors such as the increasing incidence of emerging zoonotic diseases, a growing demand for at-home immune test kits, the increasing adoption of preventive healthcare, rising investments in pandemic preparedness, and an escalating demand for transplant compatibility testing. Key trends expected during the forecast period include advancements in vaccine efficacy monitoring, the sophisticated use of AI in immune profiling, innovations in at-home immune test kits, the integration of immunotherapy into cancer treatment, and continuous advancements in transplant compatibility testing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27314&type=smp

What Are The Top Growth Drivers Impacting The Immune Response Testing Market Outlook?

The increasing incidence of autoimmune conditions is anticipated to fuel the expansion of the immune response testing market in the future. These are medical states where the body’s defense system erroneously assaults its own healthy cells and tissues. The rising occurrence of autoimmune disorders largely stems from greater exposure to environmental contaminants, which can impair immune activity and initiate immune system attacks on the body’s native tissues. Immune response testing improves the management of autoimmune diseases by offering accurate information about the body’s immune processes, facilitating prompt diagnosis and tailored therapeutic strategies. This testing aids in superior disease surveillance and contributes to better patient results via targeted adjustments in treatment. As an illustration, in November 2024, a survey conducted by Versorgungsatlas.de, a German organization, which studied 68,959,472 individuals in 2012 and 73,241,305 in 2022, revealed that among the 73,241,305 insured individuals in 2022, 6,304,340 had been diagnosed with at least one autoimmune disease, leading to a raw prevalence rate of 8.61%. Consequently, the increasing prevalence of autoimmune conditions is fueling the expansion of the immune response testing market.

What Are The Major Segment Categories Driving The Immune Response Testing Market Growth?

The immune response testing market covered in this report is segmented

1) By Type Of Testing: Antibody Testing, Cytokine Testing, Cellular Testing, Complement System Testing

2) By Application: Allergy Testing, Human Immunodeficiency Virus (HIV) Disease, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Antibody Testing: Immunoglobulin G (IgG) Testing, Immunoglobulin A (IgA) Testing, Immunoglobulin M (IgM) Testing, Neutralizing Antibody Testing, Rapid Antibody Testing

2) By Cytokine Testing: Enzyme-Linked Immunosorbent Assay (ELISA)-Based Cytokine Assays, Multiplex Cytokine Assays, Flow Cytometry-Based Cytokine Assays, Cytometric Bead Array, Quantitative Polymerase Chain Reaction (qPCR)-Based Cytokine Analysis

3) By Cellular Testing: T-Cell Response Assays, B-Cell Response Assays, Natural Killer (NK) Cell Assays, Lymphocyte Proliferation Assays, ELISpot Assays

4) By Complement System Testing: Total Hemolytic Complement (CH50) Assay, Alternative Pathway Hemolytic Complement (AH50) Assay, Complement Component 3 And 4 (C3 And C4) Complement Testing, Mannose-Binding Lectin (MBL) Testing, Complement Activity Assays

Which Ongoing Trends Are Expected To Shape The Immune Response Testing Market Outlook?

Leading entities within the immune response testing market are concentrating on creating sophisticated diagnostic options, including automated immune response assays, aiming to boost precision, improve operational effectiveness, and shorten processing durations. These automated assays are defined as advanced laboratory examinations that gauge the immune system’s activity, like antibody concentrations or cytokine patterns, requiring very little human involvement. An example of this is the introduction of the Elecsys IGRA SARS-CoV-2 test by F. Hoffmann-La Roche AG, a pharmaceutical company based in Switzerland, in August 2022. This novel test represents an automated interferon-gamma release assay (IGRA) specifically developed to identify T-cell immune responses against SARS-CoV-2, offering understanding into sustained immunity beyond what antibody tests provide. The Elecsys IGRA test functions on Roche’s cobas e analyzers, facilitating high-volume testing with quick outcomes, which is vital for extensive immune surveillance in both clinical and research environments. This progression contributes to a clearer comprehension of vaccine effectiveness and innate immunity, thereby assisting in public health policy formulation.

Which Industry Leaders Are Driving Innovation Across The Immune Response Testing Market?

Major companies operating in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, Myriad Genetics Inc., NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Immune Response Testing Market?

North America was the largest region in the immune response testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immune response testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Immune Response Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27314&type=smp

Browse Through More Reports Similar to the Global Immune Response Testing Market 2025, By The Business Research Company

Nanorobotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanorobotics-global-market-report

Nanomaterials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Nanosilica Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanosilica-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795